Efficiency in different immunotherapy of cancer: literature review
It is known that the immune system plays one of the main roles in the development of oncology. This is confirmed by the fact that patients with congenital or acquired immunodeficiency have a higher risk of developing cancer. To date, there are several types of immunotherapy, each of which has its ow...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-12-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/385 |
| _version_ | 1797702301760094208 |
|---|---|
| author | K. A. Gaptulbarova M. M. Tsyganov M. K. Ibragimova A. M. Pevzner L. V. Spirina N. V. Litviakov |
| author_facet | K. A. Gaptulbarova M. M. Tsyganov M. K. Ibragimova A. M. Pevzner L. V. Spirina N. V. Litviakov |
| author_sort | K. A. Gaptulbarova |
| collection | DOAJ |
| description | It is known that the immune system plays one of the main roles in the development of oncology. This is confirmed by the fact that patients with congenital or acquired immunodeficiency have a higher risk of developing cancer. To date, there are several types of immunotherapy, each of which has its own mechanism of action. This review presents data from clinical studies of the main treatment options using immunotherapy mechanisms, such as cellular immunotherapy, the use of antibodies and cytokines, and combination immunotherapy (using checkpoint inhibitors). These data indicate a positive trend of this method of treatment in patients with cancer. |
| first_indexed | 2024-03-12T04:48:55Z |
| format | Article |
| id | doaj.art-7e6e51dcb8194e16803c2cbc760a09e3 |
| institution | Directory Open Access Journal |
| issn | 2313-805X 2413-3787 |
| language | Russian |
| last_indexed | 2024-03-12T04:48:55Z |
| publishDate | 2021-12-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Успехи молекулярной онкологии |
| spelling | doaj.art-7e6e51dcb8194e16803c2cbc760a09e32023-09-03T09:26:37ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872021-12-018482010.17650/2313-805X-2021-8-4-8-20219Efficiency in different immunotherapy of cancer: literature reviewK. A. Gaptulbarova0M. M. Tsyganov1M. K. Ibragimova2A. M. Pevzner3L. V. Spirina4N. V. Litviakov5Научно-исследовательский институт онкологии ФГБНУ «Томский национальный исследовательский медицинский центр» Российской академии наук; ФГАОУ ВО «Национальный исследовательский Томский государственный университет»Научно-исследовательский институт онкологии ФГБНУ «Томский национальный исследовательский медицинский центр» Российской академии наукНаучно-исследовательский институт онкологии ФГБНУ «Томский национальный исследовательский медицинский центр» Российской академии наук; ФГАОУ ВО «Национальный исследовательский Томский государственный университет»Научно-исследовательский институт онкологии ФГБНУ «Томский национальный исследовательский медицинский центр» Российской академии наук; ФГАОУ ВО «Национальный исследовательский Томский государственный университет»Научно-исследовательский институт онкологии ФГБНУ «Томский национальный исследовательский медицинский центр» Российской академии наукНаучно-исследовательский институт онкологии ФГБНУ «Томский национальный исследовательский медицинский центр» Российской академии наукIt is known that the immune system plays one of the main roles in the development of oncology. This is confirmed by the fact that patients with congenital or acquired immunodeficiency have a higher risk of developing cancer. To date, there are several types of immunotherapy, each of which has its own mechanism of action. This review presents data from clinical studies of the main treatment options using immunotherapy mechanisms, such as cellular immunotherapy, the use of antibodies and cytokines, and combination immunotherapy (using checkpoint inhibitors). These data indicate a positive trend of this method of treatment in patients with cancer.https://umo.abvpress.ru/jour/article/view/385иммунотерапияклеточная иммунотерапияцитокиныингибиторы контрольных точекпрогнозэффективность лечения |
| spellingShingle | K. A. Gaptulbarova M. M. Tsyganov M. K. Ibragimova A. M. Pevzner L. V. Spirina N. V. Litviakov Efficiency in different immunotherapy of cancer: literature review Успехи молекулярной онкологии иммунотерапия клеточная иммунотерапия цитокины ингибиторы контрольных точек прогноз эффективность лечения |
| title | Efficiency in different immunotherapy of cancer: literature review |
| title_full | Efficiency in different immunotherapy of cancer: literature review |
| title_fullStr | Efficiency in different immunotherapy of cancer: literature review |
| title_full_unstemmed | Efficiency in different immunotherapy of cancer: literature review |
| title_short | Efficiency in different immunotherapy of cancer: literature review |
| title_sort | efficiency in different immunotherapy of cancer literature review |
| topic | иммунотерапия клеточная иммунотерапия цитокины ингибиторы контрольных точек прогноз эффективность лечения |
| url | https://umo.abvpress.ru/jour/article/view/385 |
| work_keys_str_mv | AT kagaptulbarova efficiencyindifferentimmunotherapyofcancerliteraturereview AT mmtsyganov efficiencyindifferentimmunotherapyofcancerliteraturereview AT mkibragimova efficiencyindifferentimmunotherapyofcancerliteraturereview AT ampevzner efficiencyindifferentimmunotherapyofcancerliteraturereview AT lvspirina efficiencyindifferentimmunotherapyofcancerliteraturereview AT nvlitviakov efficiencyindifferentimmunotherapyofcancerliteraturereview |